Skip to main content
Erschienen in: PharmacoEconomics 1/2011

01.01.2011 | Review Article

Calibrating Models in Economic Evaluation

A Seven-Step Approach

verfasst von: Dr Tazio Vanni, Jonathan Karnon, Jason Madan, Richard G. White, W. John Edmunds, Anna M. Foss, Rosa Legood

Erschienen in: PharmacoEconomics | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

In economic evaluation, mathematical models have a central role as a way of integrating all the relevant information about a disease and health interventions, in order to estimate costs and consequences over an extended time horizon. Models are based on scientific knowledge of disease (which is likely to change over time), simplifying assumptions and input parameters with different levels of uncertainty; therefore, it is sensible to explore the consistency of model predictions with observational data. Calibration is a useful tool for estimating uncertain parameters, as well as more accurately defining model uncertainty (particularly with respect to the representation of correlations between parameters). Calibration involves the comparison of model outputs (e.g. disease prevalence rates) with empirical data, leading to the identification of model parameter values that achieve a good fit.
This article provides guidance on the theoretical underpinnings of different calibration methods. The calibration process is divided into seven steps and different potential methods at each step are discussed, focusing on the particular features of disease models in economic evaluation. The seven steps are (i) Which parameters should be varied in the calibration process? (ii) Which calibration targets should be used? (iii) What measure of goodness of fit should be used? (iv) What parameter search strategy should be used? (v) What determines acceptable goodness-of-fit parameter sets (convergence criteria)? (vi) What determines the termination of the calibration process (stopping rule)? (vii) How should the model calibration results and economic parameters be integrated?
The lack of standards in calibrating disease models in economic evaluation can undermine the credibility of calibration methods. In order to avoid the scepticism regarding calibration, we ought to unify the way we approach the problems and report the methods used, and continue to investigate different methods.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Drummond MFSM, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press, 2005 Drummond MFSM, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press, 2005
2.
Zurück zum Zitat Box G, Draper N. Empirical model-building and response surfaces. 1st ed. New York: John Wiley & Sons, 1987 Box G, Draper N. Empirical model-building and response surfaces. 1st ed. New York: John Wiley & Sons, 1987
3.
Zurück zum Zitat Philips Z, Ginnelly L, Sculpher M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004 Sep; 8 (36): iii-iiv, ix-xi, 1–158PubMed Philips Z, Ginnelly L, Sculpher M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004 Sep; 8 (36): iii-iiv, ix-xi, 1–158PubMed
4.
5.
Zurück zum Zitat Weinstein MC. Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics 2006; 24 (11): 1043–53CrossRefPubMed Weinstein MC. Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics 2006; 24 (11): 1043–53CrossRefPubMed
6.
Zurück zum Zitat Van de Velde N, Brisson M, Boily M-C. Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty. Am J Epidemiol 2007 Apr 1; 165 (7): 762–75CrossRefPubMed Van de Velde N, Brisson M, Boily M-C. Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty. Am J Epidemiol 2007 Apr 1; 165 (7): 762–75CrossRefPubMed
7.
Zurück zum Zitat Jit M, Choi YH, Edmunds WJ. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008 Jul 17; 337: a769CrossRef Jit M, Choi YH, Edmunds WJ. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008 Jul 17; 337: a769CrossRef
8.
Zurück zum Zitat Stout NK, Knudsen AB, Kong CY, et al. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics 2009; 27 (7): 533–45CrossRefPubMed Stout NK, Knudsen AB, Kong CY, et al. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics 2009; 27 (7): 533–45CrossRefPubMed
12.
Zurück zum Zitat Weinstein MC, O’Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices–Modeling Studies. Value Health 2003 Jan-Feb; 6 (1): 9–17CrossRefPubMed Weinstein MC, O’Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices–Modeling Studies. Value Health 2003 Jan-Feb; 6 (1): 9–17CrossRefPubMed
13.
Zurück zum Zitat Drummond MF, McGuire A. Economic evaluation in health care: merging theory with practice. 1st ed. New York: Oxford University Press, 2001 Drummond MF, McGuire A. Economic evaluation in health care: merging theory with practice. 1st ed. New York: Oxford University Press, 2001
14.
Zurück zum Zitat Karnon J, Vanni T. Calibrating models in economic evaluation: a comparison of alternative measures of goodnessof-fit, parameter search strategies and convergence criteria. Pharmacoeconomics 2011; 29 (1): 51–62CrossRefPubMed Karnon J, Vanni T. Calibrating models in economic evaluation: a comparison of alternative measures of goodnessof-fit, parameter search strategies and convergence criteria. Pharmacoeconomics 2011; 29 (1): 51–62CrossRefPubMed
15.
Zurück zum Zitat Ades AE, Claxton K, Sculpher M. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. Health Econ 2006; 15: 373–81CrossRefPubMed Ades AE, Claxton K, Sculpher M. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. Health Econ 2006; 15: 373–81CrossRefPubMed
16.
Zurück zum Zitat Kim JJ, Kuntz KM, Stout NK, et al. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol 2007 Jul 15; 166 (2): 137–50CrossRefPubMed Kim JJ, Kuntz KM, Stout NK, et al. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol 2007 Jul 15; 166 (2): 137–50CrossRefPubMed
17.
Zurück zum Zitat Kim L, Thompson S. Uncertainty and validation of health economic decision models. Health Econ 2010; 19 (1): 43–55PubMed Kim L, Thompson S. Uncertainty and validation of health economic decision models. Health Econ 2010; 19 (1): 43–55PubMed
18.
Zurück zum Zitat Popper K. Conjectures and refutations: the growth of scientific knowledge. London: Routledge, 1963 Popper K. Conjectures and refutations: the growth of scientific knowledge. London: Routledge, 1963
19.
Zurück zum Zitat Foss AM, Watts CH, Vickerman P, et al. Could the CARESHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh? Addiction 2007; 102 (1): 114–25CrossRefPubMed Foss AM, Watts CH, Vickerman P, et al. Could the CARESHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh? Addiction 2007; 102 (1): 114–25CrossRefPubMed
20.
Zurück zum Zitat Williams JR, Foss AM, Vickerman P, et al. What is the achievable effectiveness of the India AIDS initiative intervention among female sex workers under target coverage? Model projections from southern India. Sex Transm Infect 2006; 82 (5): 372–80 Williams JR, Foss AM, Vickerman P, et al. What is the achievable effectiveness of the India AIDS initiative intervention among female sex workers under target coverage? Model projections from southern India. Sex Transm Infect 2006; 82 (5): 372–80
21.
Zurück zum Zitat Goldhaber-Fiebert JD, Stout NK, Ortendahl J, et al. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr 2007; 5 (1): 11CrossRefPubMed Goldhaber-Fiebert JD, Stout NK, Ortendahl J, et al. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr 2007; 5 (1): 11CrossRefPubMed
22.
Zurück zum Zitat Jit M, Gay N, Soldan K, et al. Estimating progression rates for human papillomavirus infection from epidemiological data. Med Decis Making 2010 Jan-Feb; 306 (1): 84–98CrossRef Jit M, Gay N, Soldan K, et al. Estimating progression rates for human papillomavirus infection from epidemiological data. Med Decis Making 2010 Jan-Feb; 306 (1): 84–98CrossRef
23.
Zurück zum Zitat Suárez E, Smith JS, Bosch FX, et al. Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios. Vaccine 2008; 26 Suppl. 5: F29–45CrossRef Suárez E, Smith JS, Bosch FX, et al. Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios. Vaccine 2008; 26 Suppl. 5: F29–45CrossRef
24.
Zurück zum Zitat Berkhof J, Bruijne MCD, Zielinski GD, et al. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. Int J Cancer 2006; 118 (7): 1759–68CrossRefPubMed Berkhof J, Bruijne MCD, Zielinski GD, et al. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. Int J Cancer 2006; 118 (7): 1759–68CrossRefPubMed
25.
Zurück zum Zitat Welton NJ, Ades AE. Estimation of markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration. Med Decis Making 2005 Nov-Dec; 25 (6): 633–45CrossRefPubMed Welton NJ, Ades AE. Estimation of markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration. Med Decis Making 2005 Nov-Dec; 25 (6): 633–45CrossRefPubMed
26.
Zurück zum Zitat Anderson R, Haas M, Shanahan M. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range? Aust N Z J Public Health 2008; 32 (1): 43–52CrossRefPubMed Anderson R, Haas M, Shanahan M. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range? Aust N Z J Public Health 2008; 32 (1): 43–52CrossRefPubMed
27.
Zurück zum Zitat Mandelblatt J, Schechter CB, Lawrence W, et al. The SPECTRUM population model of the impact of screening and treatment on US breast cancer trends from 1975 to 2000: principles and practice of the model methods. J Natl Cancer Inst Monogr 2006; (36): 47–55CrossRefPubMed Mandelblatt J, Schechter CB, Lawrence W, et al. The SPECTRUM population model of the impact of screening and treatment on US breast cancer trends from 1975 to 2000: principles and practice of the model methods. J Natl Cancer Inst Monogr 2006; (36): 47–55CrossRefPubMed
28.
Zurück zum Zitat Karnon J, Goyder E, Tappenden P, et al. A review and critique of modelling in prioritising and designing screening programmes. Health Technol Assess 2007 Dec; 11 (52): iii-iv, ix-xi, 1–145 Karnon J, Goyder E, Tappenden P, et al. A review and critique of modelling in prioritising and designing screening programmes. Health Technol Assess 2007 Dec; 11 (52): iii-iv, ix-xi, 1–145
29.
Zurück zum Zitat Pickles M, Foss AM, Vickerman P, et al. Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme. Sex Transm Infect 2010 Feb; 86 Suppl. 1: i33–43CrossRef Pickles M, Foss AM, Vickerman P, et al. Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme. Sex Transm Infect 2010 Feb; 86 Suppl. 1: i33–43CrossRef
30.
Zurück zum Zitat McMahon PM, Kong CY, Weinstein MC, et al. Adopting helical CT screening for lung cancer. Cancer 2008; 113 (12): 3440–9CrossRefPubMed McMahon PM, Kong CY, Weinstein MC, et al. Adopting helical CT screening for lung cancer. Cancer 2008; 113 (12): 3440–9CrossRefPubMed
31.
Zurück zum Zitat Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, the Netherlands, France, and Italy. J Natl Cancer Inst 2005; 97 (12): 888–95CrossRefPubMed Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, the Netherlands, France, and Italy. J Natl Cancer Inst 2005; 97 (12): 888–95CrossRefPubMed
32.
Zurück zum Zitat Press WH, Teukolsky SA, Vetterling WT, et al. Numerical recipes in C: the art of scientific computing. 2nd ed. Cambridge (NY): Cambridge University Press, 1992 Press WH, Teukolsky SA, Vetterling WT, et al. Numerical recipes in C: the art of scientific computing. 2nd ed. Cambridge (NY): Cambridge University Press, 1992
33.
Zurück zum Zitat Trotter CL, Edmunds WJ. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ 2002; 324 (7341): 809CrossRefPubMed Trotter CL, Edmunds WJ. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ 2002; 324 (7341): 809CrossRefPubMed
34.
Zurück zum Zitat Keeling M. Modeling infectious diseases in humans and animals. 1st ed. Princeton (NJ): Princeton University Press, 2007 Keeling M. Modeling infectious diseases in humans and animals. 1st ed. Princeton (NJ): Princeton University Press, 2007
35.
Zurück zum Zitat Rao SS. Engineering optimization: theory and practice. 4th ed. Chichester: John Wiley & Sons, 2009 Rao SS. Engineering optimization: theory and practice. 4th ed. Chichester: John Wiley & Sons, 2009
36.
Zurück zum Zitat Freitas AA. A critical review of multi-objective optimization in data mining: a position paper. SIGKDD Explorations 2004; 6 (2): 77–86CrossRef Freitas AA. A critical review of multi-objective optimization in data mining: a position paper. SIGKDD Explorations 2004; 6 (2): 77–86CrossRef
37.
Zurück zum Zitat Goldie SJ, Kim JJ, Kobus K, et al. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine 2007; 25 (33): 6257–70CrossRefPubMed Goldie SJ, Kim JJ, Kobus K, et al. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine 2007; 25 (33): 6257–70CrossRefPubMed
38.
Zurück zum Zitat Chung Yin K, Pamela MM, Gazelle GS. Calibration of disease simulation model using an engineering approach. Value Health 2009; 12 (4): 521–9CrossRef Chung Yin K, Pamela MM, Gazelle GS. Calibration of disease simulation model using an engineering approach. Value Health 2009; 12 (4): 521–9CrossRef
39.
Zurück zum Zitat Tappenden P, Chilcott J, Eggington S, et al. Option appraisal of population-based colorectal cancer screening programmes in England. Gut 2007 May 1; 56 (5): 677–84CrossRefPubMed Tappenden P, Chilcott J, Eggington S, et al. Option appraisal of population-based colorectal cancer screening programmes in England. Gut 2007 May 1; 56 (5): 677–84CrossRefPubMed
40.
Zurück zum Zitat Wong S. Computational methods in physics and engineering. 2nd ed. Singapore: World Scientific Publishing Co. Pte. Ltd, 1997CrossRef Wong S. Computational methods in physics and engineering. 2nd ed. Singapore: World Scientific Publishing Co. Pte. Ltd, 1997CrossRef
41.
Zurück zum Zitat Forrester M, Pettitt A, Gibson G. Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data. Biostat 2007 Apr 1; 8 (2): 383–401CrossRef Forrester M, Pettitt A, Gibson G. Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data. Biostat 2007 Apr 1; 8 (2): 383–401CrossRef
42.
Zurück zum Zitat Goldie SJ, Weinstein MC, Kuntz KM, et al. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med 1999; 130: 97–107CrossRefPubMed Goldie SJ, Weinstein MC, Kuntz KM, et al. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med 1999; 130: 97–107CrossRefPubMed
43.
44.
Zurück zum Zitat Tan SYGL, van Oortmarssen GJ, Piersma N. Estimating parameters of a microsimulation model for breast cancer screening using the score function method. Ann Operat Res 2003; 119 (1): 43–61CrossRef Tan SYGL, van Oortmarssen GJ, Piersma N. Estimating parameters of a microsimulation model for breast cancer screening using the score function method. Ann Operat Res 2003; 119 (1): 43–61CrossRef
45.
Zurück zum Zitat Vanni T, Legood R, Franco E, et al. Cost-effectiveness of strategies for managing women presenting atypical squamous cells of unknown significance in Brazil. London: London School of Hygiene and Tropical Medicine, 2008 Vanni T, Legood R, Franco E, et al. Cost-effectiveness of strategies for managing women presenting atypical squamous cells of unknown significance in Brazil. London: London School of Hygiene and Tropical Medicine, 2008
46.
Zurück zum Zitat Blower S, Dowlatabadi H. Sensitivity and uncertainty analysis of complex-models of disease transmission–an HIV model, as an example. Int Stat Rev 1994; 62 (2): 229–43CrossRef Blower S, Dowlatabadi H. Sensitivity and uncertainty analysis of complex-models of disease transmission–an HIV model, as an example. Int Stat Rev 1994; 62 (2): 229–43CrossRef
47.
Zurück zum Zitat Fylstra D, Lasdon L, Watson J, et al. Design and use of the Microsoft Excel Solver. INTERFACES 1998 Sep 1; 28 (5): 29–55CrossRef Fylstra D, Lasdon L, Watson J, et al. Design and use of the Microsoft Excel Solver. INTERFACES 1998 Sep 1; 28 (5): 29–55CrossRef
48.
Zurück zum Zitat Lasdon LS, Waren AD, Jain A, et al. Design and testing of a generalized reduced gradient code for nonlinear programming. ACM Trans Math Softw 1978; 4 (1): 34–50CrossRef Lasdon LS, Waren AD, Jain A, et al. Design and testing of a generalized reduced gradient code for nonlinear programming. ACM Trans Math Softw 1978; 4 (1): 34–50CrossRef
49.
Zurück zum Zitat Gill PE, Murray W, Wright MH. Practical optimization. San Diego (CA): Academic Press, 1981 Gill PE, Murray W, Wright MH. Practical optimization. San Diego (CA): Academic Press, 1981
51.
Zurück zum Zitat Vanni T, Legood R, White RG. Calibration of disease simulation model using an engineering approach. Value Health 2010; 13 (1): 157CrossRefPubMed Vanni T, Legood R, White RG. Calibration of disease simulation model using an engineering approach. Value Health 2010; 13 (1): 157CrossRefPubMed
52.
Zurück zum Zitat Fryback DG, Stout NK, Rosenberg MA, et al. The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 2006; (36): 37–47CrossRefPubMed Fryback DG, Stout NK, Rosenberg MA, et al. The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 2006; (36): 37–47CrossRefPubMed
53.
Zurück zum Zitat Karnon J, Czoski-Murray C, Smith KJ, et al. A hybrid cohort individual sampling natural history model of agerelated macular degeneration: assessing the cost-effectiveness of screening using probabilistic calibration. Med Decis Making 2009 May 1; 29 (3): 304–16CrossRefPubMed Karnon J, Czoski-Murray C, Smith KJ, et al. A hybrid cohort individual sampling natural history model of agerelated macular degeneration: assessing the cost-effectiveness of screening using probabilistic calibration. Med Decis Making 2009 May 1; 29 (3): 304–16CrossRefPubMed
54.
Zurück zum Zitat Karnon J, Campbell F, Czoski-Murray C. Model-based cost-effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation). J Eval Clin Pract 2009; 15 (2): 299–306CrossRefPubMed Karnon J, Campbell F, Czoski-Murray C. Model-based cost-effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation). J Eval Clin Pract 2009; 15 (2): 299–306CrossRefPubMed
55.
Zurück zum Zitat Carlton J, Karnon J, Czoski-Murray C, et al. The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4–5 years: a systematic review and economic evaluation. Health Technol Assess 2008 Jun; 12 (25): iii, xi-194 Carlton J, Karnon J, Czoski-Murray C, et al. The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4–5 years: a systematic review and economic evaluation. Health Technol Assess 2008 Jun; 12 (25): iii, xi-194
56.
Zurück zum Zitat Karnon J, Jones R, Czoski-Murray C, et al. Cost-utility analysis of screening high-risk groups for anal cancer. J Public Health 2008; 30 (3): 293–304CrossRef Karnon J, Jones R, Czoski-Murray C, et al. Cost-utility analysis of screening high-risk groups for anal cancer. J Public Health 2008; 30 (3): 293–304CrossRef
57.
Zurück zum Zitat Karnon J, McIntosh A, Dean J, et al. A prospective hazard and improvement analytic approach to predicting the effectiveness of medication error interventions. Saf Sci 2007; 45 (4): 523–39CrossRef Karnon J, McIntosh A, Dean J, et al. A prospective hazard and improvement analytic approach to predicting the effectiveness of medication error interventions. Saf Sci 2007; 45 (4): 523–39CrossRef
58.
Zurück zum Zitat Gelman A, Carlin JB, Stern HS, et al. Bayesian data analysis. 2nd ed. Boca Raton (FL): Chapman and Hall/CRC, 2004 Gelman A, Carlin JB, Stern HS, et al. Bayesian data analysis. 2nd ed. Boca Raton (FL): Chapman and Hall/CRC, 2004
59.
Zurück zum Zitat Welton NJ, Ades AE. Estimations of Markov transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis and model calibration. Med Decis Making 2005; 25 (6): 633–45CrossRefPubMed Welton NJ, Ades AE. Estimations of Markov transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis and model calibration. Med Decis Making 2005; 25 (6): 633–45CrossRefPubMed
60.
Zurück zum Zitat O’Hagan A, Buck CE, Daneshkhah A, et al. Uncertain judgements: eliciting expert probabilities. Chichester: Wiley, 2006CrossRef O’Hagan A, Buck CE, Daneshkhah A, et al. Uncertain judgements: eliciting expert probabilities. Chichester: Wiley, 2006CrossRef
61.
Zurück zum Zitat De Angelis D, Sweeting M, Ades A, et al. An evidence synthesis approach to estimating hepatitis C prevalence in England and Wales. Stat Methods Med Res 2009; 18: 361–79CrossRefPubMed De Angelis D, Sweeting M, Ades A, et al. An evidence synthesis approach to estimating hepatitis C prevalence in England and Wales. Stat Methods Med Res 2009; 18: 361–79CrossRefPubMed
62.
Zurück zum Zitat Welton NJ, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. J R Stat Soc Ser C Appl Stat 2005; 54 (2): 385–404CrossRef Welton NJ, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. J R Stat Soc Ser C Appl Stat 2005; 54 (2): 385–404CrossRef
63.
Zurück zum Zitat Goubar A, Ades AE, Angelis DD, et al. Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data. J R Stat Soc Ser A Stat Soc 2008; 171 (3): 541–80CrossRef Goubar A, Ades AE, Angelis DD, et al. Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data. J R Stat Soc Ser A Stat Soc 2008; 171 (3): 541–80CrossRef
64.
Zurück zum Zitat Morris S, Devlin N, Parkin D. Economic analysis in health care. 1st ed. Chichester: Wiley, 2007 Morris S, Devlin N, Parkin D. Economic analysis in health care. 1st ed. Chichester: Wiley, 2007
65.
Zurück zum Zitat Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. 1st ed. New York: Oxford University Press, 1996 Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. 1st ed. New York: Oxford University Press, 1996
66.
Zurück zum Zitat Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. 1st ed. Oxford: Oxford University Press, 2007 Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. 1st ed. Oxford: Oxford University Press, 2007
Metadaten
Titel
Calibrating Models in Economic Evaluation
A Seven-Step Approach
verfasst von
Dr Tazio Vanni
Jonathan Karnon
Jason Madan
Richard G. White
W. John Edmunds
Anna M. Foss
Rosa Legood
Publikationsdatum
01.01.2011
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 1/2011
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/11584600-000000000-00000

Weitere Artikel der Ausgabe 1/2011

PharmacoEconomics 1/2011 Zur Ausgabe

Correspondence

The Authors’ Reply